Hydroxyzine Imine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Hydroxyzine Imine Market is segmented by Dosage Form (Tablets, Capsules, Injection, Syrup), Indication Type, and Geography.

Hydroxyzine Imine Market Snapshot

Hydroxyzine Imine Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global hydroxyzine imine market is anticipated to witness a CAGR of nearly 5.1% during the forecast period. The increasing population with allergic reactions coupled with the geriatric population is among the key trends expected to trigger market growth. As per the Drug Database Statistic, hydroxyzine is among the top 100 brands and around 8 million prescriptions were given in the United States (2017), which is also boosting the market growth. Moreover, technological advancements with increasing investments in R&D for developing novel therapeutic drugs will also propel market growth. Increasing awareness regarding disease remittance therapies and rising healthcare expenditure in developed regions are estimated to promote revenue growth. However, side effects associated with this drug such as dizziness, skin rashes, and severe seizure may restrain the growth of the market.

Scope of the Report

Hydroxyzine imine sold under brand Atarax belongs to a group of medicines called antihistamines which is used to treat allergic reactions. It is used in adults and children to reduce itching caused by urticaria (nettle rash) and dermatitis (eczema). Atarax is also used to treat anxiety in adults.

By Dosage Form
Tablets
Capsules
Injection
Syrup
By Indication Type
Histamine-Mediated Pruritus
Urticaria
Atopic Contact Dermatoses
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Capsules​ Segment is Expected to Hold Significant Market Share in the Hydroxyzine imine Market

Capsules segment is expected to contribute significant market share attributing to ease of administration, ease of usage, easy availability and widely used in allergic reaction patients. Moreover, as hydroxyzine imine attenuates activity in the central nervous system, these properties helps hydroxyzine imine to treat anxiety associated with psychoneurosis. This is leading to adoptions of hydroxyzine imine capsules for several advantages such as stability in different ranges of temperature & humidity, physical stability, low hygroscopicity and low moisture content over others and thus boost the segment growth.

Hydroxyzine Imine Market

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is at the forefront of growth in the region and is also an important revenue contributor in the global arena. Growing geriatric population with increasing allergic patients, high public and private healthcare spending are stimulating the growth of the region. As per the Centers for Disease control and prevention, an estimated 50 million Americans suffer from allergies each year and allergies are the 6th leading cause for chronic in the US, hence promote the revenue growth in this region.

Hydroxyzine Imine Market

Competitive Landscape

The Hydroxyimine Market is moderately competitive and consists of several global as well as local players.Some of the companies which are currently dominating the market are Teva Pharmaceuticals, Pfizer, GlaxoSmithKline, Alliance Pharma, Piramal Healthcare UK Limited.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Population with Allergic Reaction

      2. 4.2.2 Rise in Geriatric Population

      3. 4.2.3 Increasing Prevalence of Anxiety Disorders

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects associated with the Medication

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Dosage Form

      1. 5.1.1 Tablets

      2. 5.1.2 Capsules

      3. 5.1.3 Injection

      4. 5.1.4 Syrup

    2. 5.2 By Indication Type

      1. 5.2.1 Histamine-Mediated Pruritus

      2. 5.2.2 Urticaria

      3. 5.2.3 Atopic Contact Dermatoses

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Teva Pharmaceuticals

      2. 6.1.2 Pfizer

      3. 6.1.3 GlaxoSmithKline

      4. 6.1.4 Alliance Pharma

      5. 6.1.5 Piramal Healthcare UK Limited

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Hydroxyzine Imine Market market is studied from 2018 - 2026.

The Hydroxyzine Imine Market is growing at a CAGR of 5.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Teva Pharmaceuticals, GlaxoSmithKline, Piramal Healthcare UK Limited, Pfizer, Alliance Pharma are the major companies operating in Hydroxyzine Imine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!